Stanfield BA, Bravo FJ, Dixon DA, Chouljenko VN, et al. Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G. Vaccine 2022 Sep 13. pii: S0264-410X(22)01119.
PMID: 36114130